Fusion event
HBV-LTO1 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
End
69483663/69668895 (Hg38)
miRNAs that regulate target gene
Nearest miRNA
hsa-mir-10392/Upstream/585637; hsa-let-7a-2/Downstream/615060;
Upstream sequence
ggagggtggatcacctgaggtcaggagttcgagaccagcctgaccaatatggtgaaaccctgtctccactaaaaatacaaaaattagatgggcgtgatag
Downstream sequence
tgtgtgcctgtagtcccagctactcgggaggctgagacaggagaattgctggaacctgggaggtggaggttgcagtgagctaagattgtgccactgcact
Target sequence
ctactaaaaatacaaaaattagccaggtgtggtggcgcatgcctgtagtcccagctactccggaggctgaggcatgaggaggtgcaggttgcactgagctgagattgcaccactgcgctccagcctgggtgacagagtgagactctgtctcaaaacaaacaaacaaacaagaaagaataaaGAGCAAAAATAGACATTGGCTCATAGAGGTATGGTCAAATTGTGCATTTATGGGCTTCATATGTTTTGCAAAGT
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.